Internal Medicine Alert - June 30, 2013

Target Audience:

This CME activity is intended for the internist/family physician.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/15/13. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing:

Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
Allan J. Wilke, MD
Professor and Chair
Program Director
Department of Family Medicine
Western Michigan University School of Medicine

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD

Clinical Assistant Professor
University of Florida

Jeffrey Gross, MD
Clinical Associate Professor of Rehabilitation Medicine
NYU School of Medicine
Adjunct Clinical Assistant Professor of Rehabilitation Medicine
Weill Cornell Medical College

David J. Pierson, MD
Professor Emeritus
Pulmonary and Critical Care Medicine
University of Washington, Seattle

Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Peer reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY


  • What's the Frequency, BP?
  • Exercise Benefits Patients with Parkinson's Disease
  • Is Your Smart Phone Spreading Infection?
  • Bedbug Detection Squad
  • Pharmacology Update: Ezetimibe and Atorvastatin Tablets (Liptruzet„¢)
  • What's the Durability of Lifestyle Change in Type 2 Diabetes?
  • Perimenstrual Asthma: A High-Risk Phenotype
  • Risk of New Onset Diabetes with Statins


  • describe new findings in differential diagnosis and treatment of various diseases
  • describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • identify cost-effective treatment regimens
  • explain the advantages and disadvantages of new disease screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Lilly, Boehringer Ingelheim, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Lilly, Kowa, Novo Nordisk, and Teva.

Associate editors Allan J. Wilke, MD, William T. Elliott, MD, FACP, , and James Chan, PharmD, PhD, Authors Jeffrey Gross, MD, and David J. Pierson, MD, Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Author Carol A. Kemper, MD, FACP does research for Abbott Laboratories and Merck.

Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda.

Copyright 2013 AHC Media LLC. All rights reserved.